Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Jounce Therapeutics, Inc. (JNCE) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/17/2022 4/A Cole Hugh M (Chief Business Officer) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Granted 85,000 options to buy @ $7.56, valued at $642.6k
07/02/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/02/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/02/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/02/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/02/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/02/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/02/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/02/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy